Brief: Herantis Pharma announces FDA clearance of IND for Phase 2 Cis-UCA Eye Drops study

Herantis Pharma Oyj

08/09/2014 06:51

Sept 8 (Reuters) - Herantis Pharma Oyj  HRTIS.HE : 
     
    * Herantis Pharma announces FDA clearance of IND for Phase 2 
study of Cis-UCA Eye Drops 
     
  
 Source text for Eikon:  ID:nHUG96wt38  
     
 Further company coverage:  HRTIS.HE   
    
    ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920)) 
 
 
Keywords: HERANTIS PHARMA/BRIEF